Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein

Cited by (581)

Items 201–300 of 581

1. Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
   María Clara Sellés, Mauricio Martins Oliveira, Sergio Teixeira Ferreira · 2018 · Journal of Alzheimer s Disease
2. mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent
   Khaled S. Abd‐Elrahman, Alison Hamilton, Awatif B. Albaker, Stephen S. G. Ferguson · 2020 · ACS Pharmacology & Translational Science
3. Metabotropic Glutamate Receptors in Central Nervous System Diseases
   Anna V. Golubeva, Rachel D. Moloney, Richard M. O’Connor, Timothy G. Dinan, John F. Cryan · 2016 · Current Drug Targets
4. Endomembrane-Based Signaling by GPCRs and G-Proteins
   Federica Liccardo, Alberto Luini, Rosaria Di Martino · 2022 · Cells
5. Eph receptors: New players in Alzheimer's disease pathogenesis
   Moustapha Cissé, Frédéric Checler · 2014 · Neurobiology of Disease
6. PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis
   Hoau-Yan Wang, Kuo-Chieh Lee, Zhe Pei, Amber Khan, Kalindi P. Bakshi, Lindsay H. Burns · 2017 · Neurobiology of Aging · Retracted
7. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model
   Levi M. Smith, Rong Zhu, Stephen M. Strittmatter · 2017 · Neuropharmacology
8. Protein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification
   Stanislav A. Bondarev, Kirill S. Antonets, Andrey V. Kajava, Anton A. Nizhnikov, Galina A. Zhouravleva · 2018 · International Journal of Molecular Sciences
9. Amyloid Beta Peptides Block New Synapse Assembly by Nogo Receptor-Mediated Inhibition of T-Type Calcium Channels
   Yanjun Zhao, Sivaprakash Sivaji, Michael C. Chiang, Haadi Ali, Monica Zukowski, Sareen T. Ali, Bryan Kennedy, Alex Sklyar, Alice Cheng, Zihan Guo et al. · 2017 · Neuron
10. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers
    Heledd Jarosz-Griffiths, Nicola J. Corbett, Helen A. Rowland, Kate Fisher, Alys C. Jones, Jennifer Baron, Gareth J. Howell, Sally A. Cowley, Satyan Chintawar, M. Zameel Cader et al. · 2019 · Journal of Biological Chemistry
11. Soluble tau aggregates inhibit synaptic long-term depression and amyloid β-facilitated LTD in vivo
    Tomáš Ondrejčák, Neng‐Wei Hu, Yingjie Qi, Igor V. Klyubin, Grant T. Corbett, Graham Mathew Fraser, Michael S. Perkinton, Dominic M. Walsh, Andrew Billinton, Michael J. Rowan · 2019 · Neurobiology of Disease
12. Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes
    Gregory J. Brewer, Robert A. Herrera, Stephan Philipp, Justyna Sosna, Jorge Mauricio Reyes‐Ruiz, Charles G. Glabe · 2019 · Journal of Alzheimer s Disease
13. Mechanisms of tau and Aβ-induced excitotoxicity
    Pallo, Susanne P., DiMaio, John, Cook, Alexis, Nilsson, Bradley, Johnson, Gail V.W. · 2016 · Brain Research
14. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [11C]ABP688
    Christine DeLorenzo, Judit Sóvágó, John D. Gardus, Jianjin Xu, Jie Yang, Rhett Behrje, J.S. Dileep Kumar, D. P. Devanand, Gregory H. Pelton, Chester A. Mathis et al. · 2015 · Translational Psychiatry
15. The 37kDa/67kDa Laminin Receptor acts as a receptor for Aβ42 internalization
    Bianca Da Costa Dias, Katarina Jovanovic, Danielle Gonsalves, Kiashanee Moodley, Uwe Reusch, Stefan H.J. Knackmuss, Marc S. Weinberg, Melvyn Little, Stefan F. T. Weiss · 2014 · Scientific Reports
16. Targeting dementias through cancer kinases inhibition
    Fagiani, Francesca, Lanni, Cristina, Racchi, Marco, Govoni, Stefano · 2020 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
17. Aβ induces its own prion protein N-terminal fragment (PrPN1)–mediated neutralization in amorphous aggregates
    Maxime Béland, Mikaël Bédard, Guillaume Tremblay, Pierre Lavigne, Xavier Roucou · 2014 · Neurobiology of Aging
18. Prion protein facilitates synaptic vesicle release by enhancing release probability
    S. W. Robinson, Marie Nugent, Dr David Dinsdale, Joern R. Steinert · 2014 · Human Molecular Genetics
19. Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers
    Hansen Wang, Lisa D. Muiznieks, Punam Ghosh, Declan Williams, Michael Solarski, Andrew Fang, Alejandro Ruiz‐Riquelme, Régis Pomès, Joel C. Watts, Avijit Chakrabartty et al. · 2017 · eLife
20. Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease
    Colom-Cadena, Martí, Toombs, Jamie, Simzer, Elizabeth, Holt, Kristjan, McGeachan, Robert, Tulloch, Jane, Jackson, Rosemary J., Catterson, James H., Spires-Jones, Maxwell P., Rose, Jamie et al. · 2024 · Acta Neuropathologica
21. Monoclonal Antibody Therapy in Alzheimer’s Disease
    Monica Neațu, Anca Covaliu, Iulia Ioniță, Ana Jugurt, Eugenia Irene Davidescu, Bogdan Ovidiu Popescu · 2023 · Pharmaceutics
22. Regulation of spine structural plasticity by Arc/Arg3.1
    Thomas M. Newpher, Scott C. Harris, Jasmine Pringle, Colleen Hamilton, Scott H. Soderling · 2017 · Seminars in Cell and Developmental Biology
23. Amyloid‐β oligomers interact with neurexin and diminish neurexin‐mediated excitatory presynaptic organization
    Naito, Yusuke, Tanabe, Yuko, Lee, Alfred Kihoon, Hamel, Edith, Takahashi, Hideto · 2017 · Scientific Reports
24. Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s disease
    Yi, Ling Xiao, Zeng, Li, Wang, Qing, Tan, Eng King, Zhou, Zhi Dong · 2024 · Ageing Research Reviews
25. Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay
    Emmanuel Risse, Andrew J. Nicoll, William A. Taylor, Daniel Wright, Mayank Badoni, Xiaofan Yang, Mark A. Farrow, John Collinge · 2015 · Journal of Biological Chemistry
26. Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo
    Emily Sempou, Emiliano Biasini, Alejandro Pinzon‐Olejua, David A. Harris, Edward Málaga Trillo · 2016 · Molecular Neurodegeneration
27. M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer’s disease pathology
    Jee Hyun Yi, Daniel J. Whitcomb, Se Jin Park, Celia Martinez-Perez, Saviana Antonella Barbati, Scott J. Mitchell, Kwangwook Cho · 2020 · Brain Communications
28. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome
    Belbin, Olivia, Xiao, Mei-Fang, Xu, Desheng, Carmona-Iragui, Maria, Pegueroles, Jordi, Benejam, Bessy, Videla, Laura, Fernández, Susana, Barroeta, Isabel, Nuñez-Llaves, Raúl et al. · 2020 · Molecular Neurodegeneration
29. A beacon of hope in stroke therapy—Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies
    Ashfaqul Hoque, Mohammed Iqbal Hossain, S. Sadia Ameen, Ching‐Seng Ang, Nicholas A. Williamson, Dominic C.H. Ng, Anderly C. Chüeh, Carli L. Roulston, Heung‐Chin Cheng · 2016 · Pharmacology & Therapeutics
30. Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes
    Laura Sartiani, Monica Bucciantini, Valentina Spinelli, Manuela Leri, Antonino Natalello, Daniele Nosi, Silvia Maria Doglia, Annalisa Relini, Amanda Penco, Sofia Giorgetti et al. · 2016 · Biophysical Journal
31. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation
    Erin Bove‐Fenderson, Ryo Urano, John E. Straub, David A. Harris · 2017 · Journal of Biological Chemistry
32. The Role of Apolipoprotein E Isoforms in Alzheimer’s Disease
    Alejandro R. Roda, Laia Montoliu‐Gaya, Sandra Villegas · 2019 · Journal of Alzheimer s Disease
33. Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease
    Caraci, Filippo, Nicoletti, Ferdinando, Copani, Agata · 2018 · Current Opinion in Pharmacology
34. Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer’s disease
    Wenzhong Yang, Xueyan Zhou, Alexey G. Ryazanov, Tao Ma · 2020 · Neurobiology of Aging
35. Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease.
    Hakimeh Zali, Mona Zamanian Azodi, Mostafa Rezaei–Tavirani, Alireza Akbarzadeh Baghban · 2015 · Europe PMC (PubMed Central)
36. Ca2+/Calmodulin-dependent protein Kinase II interacts with group I Metabotropic Glutamate and facilitates Receptor Endocytosis and ERK1/2 signaling: role of β-Amyloid
    Fitore Raka, Andrea R. Di Sebastiano, Stephanie C Kulhawy, Fabiola Mara Ribeiro, Christina M. Godin, Fabiana A. Caetano, Stéphane Angers, Stephen S. G. Ferguson · 2015 · Molecular Brain
37. Functions of the Prion Protein
    Théo Z. Hirsch, Severine Martin‐Lannerée, Sophie Mouillet‐Richard · 2017 · Progress in molecular biology and translational science
38. The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
    Khaled S. Abd‐Elrahman, Shaarika Sarasija, Stephen S. G. Ferguson · 2021 · Current Neuropharmacology
39. Metabotropic glutamate receptor, mGlu5, mediates enhancements of hippocampal long-term potentiation after environmental enrichment in young and old mice
    Arne Buschler, Denise Manahan‐Vaughan · 2016 · Neuropharmacology
40. When, where and how? Focus on neuronal calcium dysfunctions in Alzheimer’s Disease
    Mario Agostini, Cristina Fasolato · 2016 · Cell Calcium
41. Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies
    Michele M. Comerota, Batbayar Tumurbaatar, Balaji Krishnan, Rakez Kayed, Giulio Taglialatela · 2018 · Molecular Neurobiology
42. Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer´s disease
    Jonathan Mauricio Muñoz-Cabrera, Adrián Gabriel Sandoval-Hernández, Andrea Niño, Tatiana Báez, Angie Bustos-Rangel, Gloria Patricia Cardona‐Gómez, Alejandro Múnera, Gonzálo Arboleda · 2019 · PLoS ONE
43. Sleep is bi-directionally modified by amyloid beta oligomers
    Güliz Gürel Özcan, Sumi Lim, Patricia L.A. Leighton, W. Ted Allison, Jason Rihel · 2020 · eLife
44. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy
    Anna S. König, Nadine S. Rösener, Lothar Gremer, Markus Tusche, Daniel Flender, Elke Reinartz, Wolfgang Hoyer, Philipp Neudecker, Dieter Willbold, Henrike Heise · 2021 · Journal of Biological Chemistry
45. Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease
    Salasova, Alena, Monti, Giulia, Andersen, Olav M., Nykjaer, Anders · 2022 · Molecular Neurodegeneration
46. Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?
    Rebecca F. Budgett, Geor Bakker, Eugenia Sergeev, Kirstie A. Bennett, Sophie J. Bradley · 2022 · Frontiers in Pharmacology
47. Mavoglurant as a treatment for Parkinson’s disease
    Dmitry Petrov, Ignacio Pedrós, Maria Luisa de Lemos, Mercè Pallàs, Anna Maria Canudas, Alberto Lazarowski, Carlos Beas‐Zárate, Carme Auladell, Jaume Folch, Antoni Camins · 2014 · Expert Opinion on Investigational Drugs
48. Aß Facilitates LTD at Schaffer Collateral Synapses Preferentially in the Left Hippocampus
    Kenneth J. O’Riordan, Neng‐Wei Hu, Michael J. Rowan · 2018 · Cell Reports
49. Prion neurotoxicity
    Nhat T. T. Le, Bei Wu, David A. Harris · 2018 · Brain Pathology
50. Evidence for aggregation-independent, PrP C -mediated Aβ cellular internalization
    Foley, Alejandro R., Roseman, Graham P., Chan, Ka, Smart, Amanda, Finn, Thomas S., Yang, Kevin, Lokey, R. Scott, Millhauser, Glenn L., Raskatov, Jevgenij A. · 2020 · Proceedings of the National Academy of Sciences
51. Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease
    Alessio Crestini, Francesca Santilli, Stefano Martellucci, Elena Carbone, Maurizio Sorice, Paola Piscopo, Vincenzo Mattei · 2021 · Journal of Alzheimer s Disease
52. An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease
    Amy F.T. Arnsten, Kelly Del Tredici, Nicolas R. Barthélemy, Mariano I. Gabitto, Christopher H. van Dyck, Edward S. Lein, Heiko Braak, Dibyadeep Datta · 2025 · Alzheimer s & Dementia
53. Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus
    Nadine S. Rösener, Lothar Gremer, Michael M. Wördehoff, Tatsiana Kupreichyk, Manuel Etzkorn, Philipp Neudecker, Wolfgang Hoyer · 2020 · Communications Biology
54. Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists
    Erik C. Gunther, Levi M. Smith, Mikhail A. Kostylev, Timothy O. Cox, Adam C. Kaufman, Suho Lee, Ewa J Folta‐Stogniew, George D. Maynard, Ji Won Um, Massimiliano Stagi et al. · 2019 · Cell Reports
55. GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders
    Ferdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, Rosamaria Orlando, Anna Rita Zuena, Peter Jeffrey Conn, Shalini Dogra, Max E. Joffe · 2023 · Neuropharmacology
56. Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer’s-Associated Aβ Oligomers
    Kyle C. Wilcox, Matthew R. Marunde, Aditi Das, Pauline T. Velasco, Benjamin D. Kuhns, Michael Thomas Marty, Jiang Haoming, Chi-Hao Luan, Stephen G. Sligar, William L. Klein · 2015 · PLoS ONE
57. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease
    Paula Maria Quaglio Bellozi, Giovanni Freitas Gomes, Maria Carolina Machado da Silva, Isabel Vieira de Assis Lima, Carla Ribeiro Álvares Batista, Wellerson de Oliveira Carneiro, Juliana G. Doria, Érica Leandro Marciano Vieira, Rafael Pinto Vieira, Rossimiriam Pereira de Freitas et al. · 2019 · Neuropharmacology
58. A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe /PSEN1ΔE9 mice
    Khaled S. Abd‐Elrahman, Shaarika Sarasija, Tash‐Lynn L. Colson, Stephen S. G. Ferguson · 2021 · British Journal of Pharmacology
59. Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies
    Luise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, Karl Frontzek, Julia Bär, Amulya Nidhi Shrivastava, Markus Daμμe, Feizhi Song, Alexander Schwarz, Stefano Da Vela et al. · 2021 · Science Advances
60. Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity
    Miyamoto, Takashi, Kim, Daniel, Knox, Joseph A., Johnson, Erik, Mucke, Lennart · 2016 · Journal of Biological Chemistry
61. PrPC signalling in neurons: From basics to clinical challenges
    Théo Z. Hirsch, Julia Hernandez-Rapp, Severine Martin‐Lannerée, Jean‐Marie Launay, Sophie Mouillet‐Richard · 2014 · Biochimie
62. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [11C]ABP688 PET imaging and ex vivo immunoblotting
    Xiaotian T. Fang, Jonas Eriksson, Gunnar Antoni, Ulrika Yngve, Linda Cato, Lars Lannfelt, Dag Sehlin, Stina Syvänen · 2016 · Neuropharmacology
63. Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer’s disease: A review on experimental progress and computational modeling
    Jingyi Liang, Don Kulasiri, Sandhya Samarasinghe · 2015 · Biosystems
64. Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
    Ernest James Phillips, Thomas, Maguire, Emily · 2021 · Frontiers in Cellular Neuroscience
65. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
    A. Harrison Brody, Sarah Helena Nies, Fulin Guan, Levi M. Smith, Bandhan Mukherjee, Santiago A. Salazar, Suho Lee, Tu Kiet T. Lam, Stephen M. Strittmatter · 2022 · Molecular Neurodegeneration
66. Acute intracerebral treatment with amyloid-beta (1–42) alters the profile of neuronal oscillations that accompany LTP induction and results in impaired LTP in freely behaving rats
    Alexander Nikolai Kalweit, Honghong Yang, Jens Colitti-Klausnitzer, Lívia Fülöp, Zsolt BozsÃ, Botond Penke, Denise Manahan‐Vaughan · 2015 · Frontiers in Behavioral Neuroscience
67. Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET Imaging
    Sadasivam, Pragalath, Fang, Xiaotian T., Toyonaga, Takuya, Lee, Supum, Xu, Yuping, Zheng, Ming-Qiang, Spurrier, Joshua, Huang, Yiyun, Strittmatter, Stephen M., Carson, Richard E. et al. · 2021 · Molecular Imaging and Biology
68. A Genome Wide Association Study Links Glutamate Receptor Pathway to Sporadic Creutzfeldt-Jakob Disease Risk
    Pascual Sánchez‐Juan, Matthew Bishop, Gábor Géza Kovács, Miguel Calero, Yurii S. Aulchenko, Anna Ladogana, Alison Boyd, Victoria Lewis, Claudia Ponto, Olga Calero et al. · 2015 · PLoS ONE
69. Neuronal transcriptome, tau and synapse loss in Alzheimer’s knock-in mice require prion protein
    Austin J. Stoner, Li Fu, LaShae Nicholson, Chao Zheng, Takuya Toyonaga, Joshua M. Spurrier, Will Laird, Zhengxin Cai, Stephen M. Strittmatter · 2023 · Alzheimer s Research & Therapy
70. Fragile X and APP: a Decade in Review, a Vision for the Future
    Cara J. Westmark · 2018 · Molecular Neurobiology
71. A potential biomarker of preclinical Alzheimer’s disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments
    Yan Yan, Ailikemu Aierken, Chunjian Wang, Da Feng Song, Junjun Ni, Zhe Wang, Zhenzhen Quan, Hong Qing · 2021 · Neuroscience & Biobehavioral Reviews
72. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies
    Dainan Zhang, Yingjie Qi, Igor V. Klyubin, Tomáš Ondrejčák, Claire J. Sarell, A. Claudio Cuello, John Collinge, Michael J. Rowan · 2017 · Neuropharmacology
73. Anti‐PrPC antibody rescues cognition and synapses in transgenic alzheimer mice
    Cox, Timothy O., Gunther, Erik C., Brody, A. Harrison, Chiasseu, Marius T., Stoner, Austin, Smith, Levi M., Haas, Laura T., Hammersley, Jayne, Rees, Gareth, Dosanjh, Bhupinder et al. · 2019 · Annals of Clinical and Translational Neurology
74. Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications
    Ilaria Dal Prà, Ubaldo Armato, Anna Chiarini · 2019 · Frontiers in Pharmacology
75. The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease
    Annibale Antonioni, Alessandro Martorana, Emiliano Santarnecchi, Harald Juergen Hampel, Giacomo Koch · 2025 · Alzheimer s & Dementia
76. The soluble extracellular fragment of neuroligin-1 targets Aβ oligomers to the postsynaptic region of excitatory synapses
    Margarita C. Dinamarca, Mónica Di Luca, Juan Alejandro Godoy, Nibaldo C. Inestrosa · 2015 · Biochemical and Biophysical Research Communications
77. Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
    Lindsay H. Burns, Hoau-Yan Wang · 2017 · Neuroimmunology and Neuroinflammation
78. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer’s Disease
    Zhao-Jun Wang, Fang Zhao, Chen-Fang Wang, Xiumin Zhang, Yi Xiao, Fang Zhou, Meina Wu, Jun Zhang, Jin‐Shun Qi, Wei Yang · 2019 · Journal of Alzheimer s Disease
79. Mechanisms of prion-induced toxicity
    Robert C.C. Mercer, David A. Harris · 2022 · Cell and Tissue Research
80. LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer’s Disease
    Emma C. Pinnock, Katarina Jovanovic, Maxine G. Pinto, Eloise Ferreira, Bianca Da Costa Dias, Clement Brian Penny, Stefan H.J. Knackmuss, Uwe Reusch, Melvyn Little, Hermann M. Schätzl et al. · 2015 · Journal of Alzheimer s Disease
81. Domains of STIP1 responsible for regulating PrPC-dependent amyloid-β oligomer toxicity
    Andrzej Maciejewski, Valeriy G. Ostapchenko, Flávio H. Beraldo, Vânia F. Prado, Marco A. M. Prado, Wing‐Yiu Choy · 2016 · Biochemical Journal
82. Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes
    Luiza Moreira Gomes, Janaina C. Bataglioli, Allison J. Jussila, Jason R. Smith, Charles J. Walsby, Tim Storr · 2019 · Frontiers in Chemistry
83. Dual Specificity Phosphatase 6 Protects Neural Stem Cells from β-Amyloid-Induced Cytotoxicity through ERK1/2 Inactivation
    Wang Liao, Yuqiu Zheng, Wenli Fang, Shaowei Liao, Ying Xiong, Yi Li, Songhua Xiao, Xingcai Zhang, Jun Liu · 2018 · Biomolecules
84. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment
    Jie Wang, Qi Huang, Kun He, Junpeng Li, Tengfei Guo, Yang Yang, Zengping Lin, Songye Li, Greet Vanderlinden, Yiyun Henry Huang et al. · 2024 · Alzheimer s & Dementia
85. Protein aggregation and prionopathies
    Marianne L. Renner, Ronald Melki · 2014 · Pathologie Biologie
86. The prion protein constitutively controls neuronal store-operated Ca2+ entry through Fyn kinase
    Agnese De Mario, Angela Castellani, Caterina Peggion, Maria Lina Massimino, Dmitry Lim, Andrew Francis Hill, Maria Catia Sorgato, Alessandro Bertoli · 2015 · Frontiers in Cellular Neuroscience
87. Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease
    Jacqueline K. Heiss, Joshua Barrett, Zizi Yu, Laura T. Haas, Mikhail A. Kostylev, Stephen M. Strittmatter · 2016 · Cerebral Cortex
88. Role of cellular prion protein in interneuronal amyloid transmission
    José Antonio del Rı́o, Isidró Ferrer, Rosalina Gavı́n · 2018 · Progress in Neurobiology
89. Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice
    Danielle Beckman, Luís E. Santos, Tatiana A. Americo, José Henrique Ledo, Fernando Garcia De Mello, Rafael Linden · 2015 · Journal of Biological Chemistry
90. Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn
    D. Xia, J. Götz · 2014 · Frontiers in Molecular Neuroscience
91. Role of ASIC1a in Aβ-induced synaptic alterations in the hippocampus
    Dalila Mango, Robert Nisticò · 2018 · Pharmacological Research
92. Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective
    Naomi Scarano, Francesca Musumeci, Beatrice Casini, Chiara Brullo, Pasqualina D’Ursi, Paola Fossa, Silvia Schenone, Elena Cichero · 2025 · International Journal of Molecular Sciences
93. Reduced uptake of [11C]‐ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer’s dementia
    Valérie Treyer, Anton Franz Gietl, Husam Suliman, Esmeralda Gruber, Rafael Meyer, Andreas Buchmann, Anass Johayem, Paul Gerson Unschuld, Roger M. Nitsch, Alfred Buck et al. · 2020 · Brain and Behavior
94. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases
    Giuseppe Legname, Carlo Scialò · 2020 · Prion
95. Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains
    Reisuke H. Takahashi, Mayumi Yokotsuka, Minoru Tobiume, Yuko Sato, Hideki Hasegawa, Toshitaka Nagao, Gunnar K. Gouras · 2021 · Brain Pathology
96. Group I Metabotropic Glutamate Receptors and Interacting Partners: An Update
    Limin Mao, Alaya Bodepudi, Xiang‐Ping Chu, John Q. Wang · 2022 · International Journal of Molecular Sciences
97. The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease
    Moustapha Cissé, Eric Duplan, Frédéric Checler · 2016 · Molecular Medicine
98. Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
    Eleanor Drummond, Fernando Goñi, Shan Liu, Frances Prelli, Henrieta Scholtzova, Thomas Wısnıewskı · 2018 · Journal of Alzheimer s Disease
99. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein
    Nadine S. Rösener, Lothar Gremer, Elke Reinartz, Anna König, Oleksandr Brener, Henrike Heise, Wolfgang Hoyer, Philipp Neudecker, Dieter Willbold · 2018 · Journal of Biological Chemistry
100. Fyn depletion ameliorates tauP301L-induced neuropathology
     Guanghao Liu, Kimberly L. Fiock, Yona Levites, Todd Eliot Golde, Marco M. Hefti, Gloria S. Lee · 2020 · Acta Neuropathologica Communications